Covered recipient · General Payments record
WULF HIRSCHFIELD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,847.34
- Reported across 119 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $353.93 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $187.21 | 19 |
| Lilly USA, LLC | $49.49 | 3 |
| Merck Sharp & Dohme Corporation | $24.25 | 1 |
| Mylan Specialty L.P. | $24.22 | 1 |
| Xeris Pharmaceuticals, Inc. | $20.28 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.55 | 1 |
| Amgen Inc. | $15.60 | 1 |
| Exact Sciences Corporation | $14.33 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $14.25 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922511 | CMS |
| ABBVIE INC. | $5.13 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922513 | CMS |
| ABBVIE INC. | $5.64 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922515 | CMS |
| ABBVIE INC. | $2.87 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922517 | CMS |
| ABBVIE INC. | $30.79 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922519 | CMS |
| ABBVIE INC. | $9.96 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922521 | CMS |
| ABBVIE INC. | $10.22 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922523 | CMS |
| ABBVIE INC. | $6.57 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922525 | CMS |
| ABBVIE INC. | $10.26 | 04/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922527 | CMS |
| ABBVIE INC. | $6.22 | 04/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922529 | CMS |
| ABBVIE INC. | $9.56 | 05/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922531 | CMS |
| ABBVIE INC. | $10.33 | 05/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922533 | CMS |
| ABBVIE INC. | $16.03 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922535 | CMS |
| ABBVIE INC. | $6.37 | 06/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922537 | CMS |
| ABBVIE INC. | $3.78 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922539 | CMS |
| ABBVIE INC. | $13.68 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922541 | CMS |
| ABBVIE INC. | $4.66 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922543 | CMS |
| ABBVIE INC. | $11.62 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922545 | CMS |
| ABBVIE INC. | $9.27 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103922547 | CMS |
| Amgen Inc. | $15.60 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115721857 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $18.55 | 05/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117880103 | CMS |
| Exact Sciences Corporation | $14.33 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114703682 | CMS |
| Lilly USA, LLC | $18.72 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135501930 | CMS |
| Lilly USA, LLC | $15.05 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135508518 | CMS |
| Lilly USA, LLC | $15.72 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135474092 | CMS |
| Merck Sharp & Dohme LLC | $24.25 | 03/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141870199 | CMS |
| Mylan Specialty L.P. | $24.22 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147290156 | CMS |
| Xeris Pharmaceuticals, Inc. | $20.28 | 10/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144617763 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.